OpenAI’s confidential SEC filing and internal deliberations have solidified trader consensus around a 2027 timeline, as CEO Sam Altman rejects any IPO below the $1 trillion target amid volatile public tech markets and SpaceX’s post-listing share slump. Recent statements from Altman highlight prioritizing AI safety work and infrastructure commitments over an accelerated debut, while CFO Sarah Friar has signaled a 2027 window unless revenue inflects sharply. Heavy ongoing losses, stalled user growth in some segments, and sequencing risks relative to rival Anthropic further support the near-certain “no” odds. A sudden market rebound or regulatory greenlight enabling a premium valuation could still shift the outcome before year-end 2026, though no such catalysts appear imminent.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertJa
$312,553 Vol.
$312,553 Vol.
Ja
$312,553 Vol.
$312,553 Vol.
An “initial public offering (IPO)” refers to the first sale of OpenAI’s equity securities to the public through a regulated stock exchange.
OpenAI will be considered to have achieved a $1 trillion valuation if the market capitalization implied by the IPO offering price multiplied by the total number of outstanding shares equals or exceeds $1 trillion USD.
Announcements, filings, or planned IPOs that do not result in public trading by that time will not qualify. Private funding rounds, secondary share sales, or employee-share transactions will not be considered. A direct listing or merger via SPAC will qualify only if it results in OpenAI’s common shares becoming publicly traded for the first time on a major exchange.
If OpenAI’s IPO is priced before the resolution deadline but public trading has not yet commenced, the market may remain open for up to 30 calendar days to determine whether the IPO is completed.
If OpenAI is acquired, dissolved, or merged into another entity before an IPO occurs, this market will resolve to “No.” In the event of a restructuring, the market will resolve based on the entity legally recognized as OpenAI’s successor will
The resolution source will be a consensus for credible reporting.
Markt eröffnet: Oct 29, 2025, 8:29 PM ET
Abwickler
0x65070be91...An “initial public offering (IPO)” refers to the first sale of OpenAI’s equity securities to the public through a regulated stock exchange.
OpenAI will be considered to have achieved a $1 trillion valuation if the market capitalization implied by the IPO offering price multiplied by the total number of outstanding shares equals or exceeds $1 trillion USD.
Announcements, filings, or planned IPOs that do not result in public trading by that time will not qualify. Private funding rounds, secondary share sales, or employee-share transactions will not be considered. A direct listing or merger via SPAC will qualify only if it results in OpenAI’s common shares becoming publicly traded for the first time on a major exchange.
If OpenAI’s IPO is priced before the resolution deadline but public trading has not yet commenced, the market may remain open for up to 30 calendar days to determine whether the IPO is completed.
If OpenAI is acquired, dissolved, or merged into another entity before an IPO occurs, this market will resolve to “No.” In the event of a restructuring, the market will resolve based on the entity legally recognized as OpenAI’s successor will
The resolution source will be a consensus for credible reporting.
Abwickler
0x65070be91...OpenAI’s confidential SEC filing and internal deliberations have solidified trader consensus around a 2027 timeline, as CEO Sam Altman rejects any IPO below the $1 trillion target amid volatile public tech markets and SpaceX’s post-listing share slump. Recent statements from Altman highlight prioritizing AI safety work and infrastructure commitments over an accelerated debut, while CFO Sarah Friar has signaled a 2027 window unless revenue inflects sharply. Heavy ongoing losses, stalled user growth in some segments, and sequencing risks relative to rival Anthropic further support the near-certain “no” odds. A sudden market rebound or regulatory greenlight enabling a premium valuation could still shift the outcome before year-end 2026, though no such catalysts appear imminent.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert


Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen